Cosmos Health Inc. Expected to Earn Q1 2025 Earnings of ($0.07) Per Share (NASDAQ:COSM)

Cosmos Health Inc. (NASDAQ:COSM) – Stock analysts at Taglich Brothers issued their Q1 2025 earnings per share (EPS) estimates for Cosmos Health in a research note issued to investors on Monday, September 16th. Taglich Brothers analyst H. Halpern anticipates that the company will post earnings of ($0.07) per share for the quarter. The consensus estimate for Cosmos Health’s current full-year earnings is ($0.47) per share. Taglich Brothers also issued estimates for Cosmos Health’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at $0.03 EPS, Q4 2025 earnings at $0.03 EPS and FY2025 earnings at ($0.05) EPS.

Cosmos Health Trading Down 2.6 %

Shares of COSM opened at $1.11 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 1.17 and a debt-to-equity ratio of 0.07. The stock has a fifty day moving average price of $1.16 and a 200-day moving average price of $0.87. Cosmos Health has a 12 month low of $0.47 and a 12 month high of $2.05.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Tuesday, August 20th. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.05. Cosmos Health had a negative return on equity of 5.83% and a negative net margin of 38.19%. The firm had revenue of $13.21 million for the quarter, compared to analysts’ expectations of $15.25 million.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Cosmos Health stock. Armistice Capital LLC bought a new stake in Cosmos Health Inc. (NASDAQ:COSM) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned about 7.89% of Cosmos Health as of its most recent filing with the Securities and Exchange Commission. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.